Cancer Research 2010 AACR Elections  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, R.
Right arrow Articles by Zhang, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, R.
Right arrow Articles by Zhang, N.
[Cancer Research 65, 1433-1441, February 15, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Protein Kinase C {zeta} Is Required for Epidermal Growth Factor–Induced Chemotaxis of Human Breast Cancer Cells

Ronghua Sun1, Ping Gao3, Lin Chen1, Dalong Ma2, Jiming Wang3, Joost J. Oppenheim3 and Ning Zhang1,3

1 Department of Chemical Biology and State Key Laboratory of Molecular Dynamic and Stable Structures, College of Chemistry and 2 Laboratory of Medical Immunology, School of Basic Medical Science, Peking University, Beijing, China; and 3 Laboratory of Molecular Immunoregulation, Center for Cancer Research, Intramural Research Support Program, National Cancer Institute, Frederick, Maryland

Requests for reprints: Ning Zhang, Department of Chemical Biology and State Key Laboratory of Molecular Dynamic and Stable Structures, College of Chemistry, Peking University, Beijing 100871, P.R. China. Phone: 86-10-62755154; Fax: 86-10-62751708; E-mail: zhangnz{at}pku.edu.cn.

Chemotaxis plays an important role in cancer cell metastasis. In this study, we showed that epidermal growth factor (EGF) was a more potent chemoattractant than chemokine SDF-1{alpha}/CXCL12 for human breast cancer cell MDA-MB-231. Different inhibitors were used to evaluate the involvement of 12 protein kinase C (PKC) isotypes in the chemotactic signaling pathway. Chelerythrine chloride, an inhibitor of all PKC isotypes, blocked chemotaxis, whereas inhibitors of classic and novel PKC, such as Gö6976, Gö6850, or calphostin C, only impaired EGF-induced chemotaxis to a minor extent by 32% inhibition. These data suggested that atypical PKC were involved. The ligand-induced actin polymerization and cell adhesion were also similarly dependent on atypical PKC. Immunofluorescent staining showed an EGF-induced, LY294002-sensitive translocation of PKC{zeta} from the cytosol to the plasma membrane, indicating that EGF was capable of activating PKC{zeta}, probably via phosphoinositide 3 kinases. A myristoylated PKC{zeta} pseudosubstrate blocked the chemotaxis with an IC50 of 20 µmol/L. To expand our investigation, we further showed that in MCF-7 and T47D, two additional human breast cancer cell lines, EGF-activated PKC{zeta} and the PKC{zeta} pseudosubstrate, inhibited chemotaxis. Taken together, our data suggest that PKC{zeta} is an essential component of the EGF-stimulated chemotactic signaling pathway in human breast cancer cells.

Key Words: chemotaxis • EGF • PKC{zeta} • metastasis




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
H. Guo, Y. Ma, B. Zhang, B. Sun, R. Niu, G. Ying, and N. Zhang
Pivotal Advance: PKC{zeta} is required for migration of macrophages
J. Leukoc. Biol., June 1, 2009; 85(6): 911 - 918.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Y. Liu, J. Wang, M. Wu, W. Wan, R. Sun, D. Yang, X. Sun, D. Ma, G. Ying, and N. Zhang
Down-Regulation of 3-Phosphoinositide-Dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells
Mol. Cancer Res., June 1, 2009; 7(6): 944 - 954.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Barros, C. Srimaroeng, J. L. Perry, R. Walden, N. Dembla-Rajpal, D. H. Sweet, and J. B. Pritchard
Activation of Protein Kinase C{zeta} Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport
J. Biol. Chem., January 30, 2009; 284(5): 2672 - 2679.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Assidi, I. Dufort, A. Ali, M. Hamel, O. Algriany, S. Dielemann, and M.-A. Sirard
Identification of Potential Markers of Oocyte Competence Expressed in Bovine Cumulus Cells Matured with Follicle-Stimulating Hormone and/or Phorbol Myristate Acetate In Vitro
Biol Reprod, August 1, 2008; 79(2): 209 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Woo, A. K. Dutta, V. Patel, C. Kresge, and A. P. Feranchak
Fluid flow induces mechanosensitive ATP release, calcium signalling and Cl- transport in biliary epithelial cells through a PKC{zeta}-dependent pathway
J. Physiol., June 1, 2008; 586(11): 2779 - 2798.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Lee and V. Vasioukhin
Cell polarity and cancer - cell and tissue polarity as a non-canonical tumor suppressor
J. Cell Sci., April 15, 2008; 121(8): 1141 - 1150.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. Lerner-Marmarosh, T. Miralem, P. E. M. Gibbs, and M. D. Maines
Regulation of TNF-{alpha}-activated PKC-{zeta} signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase
FASEB J, December 1, 2007; 21(14): 3949 - 3962.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Pu, M. L. Peach, S. H. Garfield, S. Wincovitch, V. E. Marquez, and P. M. Blumberg
Effects on Ligand Interaction and Membrane Translocation of the Positively Charged Arginine Residues Situated along the C1 Domain Binding Cleft in the Atypical Protein Kinase C Isoforms
J. Biol. Chem., November 3, 2006; 281(44): 33773 - 33788.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
W.-S. Wu, R. K. Tsai, C. H. Chang, S. Wang, J.-R. Wu, and Y.-X. Chang
Reactive Oxygen Species Mediated Sustained Activation of Protein Kinase C {alpha} and Extracellular Signal-Regulated Kinase for Migration of Human Hepatoma Cell Hepg2
Mol. Cancer Res., October 1, 2006; 4(10): 747 - 758.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. A. Teicher
Protein kinase C as a therapeutic target.
Clin. Cancer Res., September 15, 2006; 12(18): 5336 - 5345.
[Full Text] [PDF]


Home page
Cancer Res.Home page
E. E. W. Cohen, M. W. Lingen, B. Zhu, H. Zhu, M. W. Straza, C. Pierce, L. E. Martin, and M. R. Rosner
Protein Kinase C{zeta} Mediates Epidermal Growth Factor-Induced Growth of Head and Neck Tumor Cells by Regulating Mitogen-Activated Protein Kinase.
Cancer Res., June 15, 2006; 66(12): 6296 - 6303.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Qi, N. Chen, J. Wang, and C.-H. Siu
Transendothelial Migration of Melanoma Cells Involves N-Cadherin-mediated Adhesion and Activation of the {beta}-Catenin Signaling Pathway
Mol. Biol. Cell, September 1, 2005; 16(9): 4386 - 4397.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Wang, J. Silva, K. Krishnamurthy, E. Tran, B. G. Condie, and E. Bieberich
Direct Binding to Ceramide Activates Protein Kinase C{zeta} before the Formation of a Pro-apoptotic Complex with PAR-4 in Differentiating Stem Cells
J. Biol. Chem., July 15, 2005; 280(28): 26415 - 26424.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.